About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2013 (2013), Article ID 157103, 8 pages
Review Article

HMGB1: A Promising Therapeutic Target for Prostate Cancer

1Department of Biomedical Sciences, College of Medicine, University of Illinois, 1601 Parkview Avenue, Rockford, IL 61107, USA
2Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA

Received 28 February 2013; Accepted 15 April 2013

Academic Editor: J. W. Moul

Copyright © 2013 Munirathinam Gnanasekar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Xue Rui, Ma Shengli, Jia Zhankui, Pi Guofu, and Yang Jinjian, “HMGB1: A potential target for treatment of benign prostatic hyperplasia,” Medical Hypotheses, 2013. View at Publisher · View at Google Scholar
  • Y. Liu, L. Zhao, Y. Ju, W. Li, M. Zhang, Y. Jiao, J. Zhang, S. Wang, Y. Wang, M. Zhao, B. Zhang, and Y. Zhao, “A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF),” Cell Death & Disease, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Madhuwanti Srinivasan, Souresh Banerjee, Allison Palmer, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland, André Kajdacsy-Balla, Ramaswamy Kalyanasundaram, and Gnanasekar Munirathinam, “HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target,” Hormones and Cancer, 2014. View at Publisher · View at Google Scholar
  • Siegfried Wagner, Anaclet Ngezahayo, Hugo Murua Escobar, and Ingo Nolte, “ Role of miRNA Let-7 and Its Major Targets in Prostate Cancer ,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Parth Malik, Narender Chaudhry, Rashmi Mittal, and Tapan K. Mukherjee, “Role of receptor for advanced glycation end products in the complication and progression of various types of cancers,” Biochimica Et Biophysica Acta-General Subjects, vol. 1850, no. 9, pp. 1898–1904, 2015. View at Publisher · View at Google Scholar
  • Xiao Shen, and Wei-Qin Li, “High-mobility group box 1 protein and its role in severe acute pancreatitis,” World Journal Of Gastroenterology, vol. 21, no. 5, pp. 1424–1435, 2015. View at Publisher · View at Google Scholar
  • Yanmei Chen, Chengzhao Lin, Yang Liu, and Yan Jiang, “HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Guozhe Xian, Juan Zhao, Chengkun Qin, Zhenhai Zhang, Yanliang Lin, and Zhongxue Su, “Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Yanmei Li, Ping Wang, Jia Zhao, Haonan Li, Dahai Liu, and Wei Zhu, “HMGB1 attenuates TGF-β-induced epithelial–mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression,” Molecular and Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar